
北美滴眼液市场预测至 2030 年 – 区域分析 – 按类型(抗生素、人工泪液、激素等)、应用{眼部疾病(干眼、青光眼、白内障等)、眼部护理和其他}、购买方式(OTC 和处方)
No. of Pages: 87 | Report Code: BMIRE00029070 | Category: Life Sciences
No. of Pages: 87 | Report Code: BMIRE00029070 | Category: Life Sciences
导致视力损害的糖尿病视网膜病变、青光眼和干眼症等眼科疾病的发病率在人群中不断上升,尤其是在发达国家。干眼症是由多种因素引起的,这些因素会导致不适、刺激和视力障碍。根据 2020 年 4 月在美国进行的一项“全国健康与健康调查”研究,约有 1640 万人被诊断患有干眼症。数据还表明,18岁至34岁人群中的患病率激增了2.7%。据 Novaliq GmbH 称,目前约有 1700 万美国人患有干眼病。
糖尿病视网膜病变代表微血管终末器官损伤。它从非增殖性糖尿病视网膜病变阶段进展为增殖性糖尿病视网膜病变。随着疾病的进展,相关的糖尿病性黄斑水肿也可能变得明显。根据美国眼科学会发表的一篇文章,预计到 2030 年,全球将有 1.91 亿人患有糖尿病视网膜病变。据 Medscape 报道,美国约有 700,000 人患有增殖性糖尿病视网膜病变,每年新增病例约 65,000 例。
根据《世界》杂志发表的一篇文章世界卫生组织 (WHO) 预计,到 2022 年,全球约有 22 亿人患有近视力或远视力障碍。视力障碍的主要原因是白内障(约 9400 万例)和未矫正的屈光不正(约 8840 万例)。医生通常会开眼药水来治疗和预防眼科疾病。因此,眼科疾病日益流行正在推动北美滴眼液市场的增长。
北美滴眼液市场已细分为美国、加拿大和墨西哥。该地区的市场增长归因于人们对干眼症的认识不断提高、人口老龄化的增加以及眼部治疗程序的技术进步以及眼部疾病发病率的上升。干眼病在美国是一种常见但诊断不足的疾病。不断增长的老年人口进一步引发了干眼病的流行。根据美国疾病控制与预防中心 (CDC) 的数据,黄斑变性、白内障、糖尿病性视网膜病变和青光眼等与年龄相关的眼病是美国失明和低视力的主要原因。该国报告的其他常见眼部疾病包括弱视和斜视。随着人口老龄化以及年轻人接受屈光手术的频率增加,预计到 2030 年,干眼症将影响多达 279 万美国男性。
美国是北美滴眼液市场最大且增长最快的国家。该国的市场归因于人们干眼病发病率的增加。美国有多家公司提供不同的眼药水和镜片来治疗干眼症。此外,不断增长的医疗保健支出有利于美国北美滴眼液市场的增长。
北美滴眼液市场细分
北美滴眼液市场按类型、应用、购买模式和国家/地区进行细分。
<根据类型,北美滴眼液市场分为抗生素、人工泪液、激素等。 2022年,抗生素细分市场在北美滴眼液市场中占据最大份额。
根据应用,北美滴眼液市场细分为眼病、眼科、护理,以及其他。 2022年,眼病细分市场在北美滴眼液市场中占据最大份额。眼病细分市场进一步细分为干眼症、青光眼、白内障等。
根据购买模式,北美滴眼剂市场分为非处方药和处方药。 2022 年,处方药细分市场在北美滴眼液市场中占据较大份额。
按国家/地区划分,北美滴眼液市场分为美国、加拿大、和墨西哥。 2022 年,美国在北美滴眼液市场占据主导地位。
AbbVie Inc、Akorn Operating Company LLC、Alcon AG、Bausch & Co. Lomb Inc、辉瑞公司、Prestige Consumer Healthcare Inc.、乐敦制药有限公司和 Similasan Corp是北美滴眼液市场上的一些领先公司。
Strategic insights for North America Eye Drops involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 8,030.88 Million |
Market Size by 2030 | US$ 12,289.12 Million |
Global CAGR (2022 - 2030) | 5.5% |
Historical Data | 2020-2021 |
Forecast period | 2023-2030 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Eye Drops refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Eye Drops Market is valued at US$ 8,030.88 Million in 2022, it is projected to reach US$ 12,289.12 Million by 2030.
As per our report North America Eye Drops Market, the market size is valued at US$ 8,030.88 Million in 2022, projecting it to reach US$ 12,289.12 Million by 2030. This translates to a CAGR of approximately 5.5% during the forecast period.
The North America Eye Drops Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Eye Drops Market report:
The North America Eye Drops Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Eye Drops Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Eye Drops Market value chain can benefit from the information contained in a comprehensive market report.